Company intelligence / Profile preview

ARANZ Medical

Christchurch, New Zealand

Ownership: Private
Development stage: Other

Overview

ARANZ Medical's primary product is Silhouette, a global leader in electronic wound assessment systems and an end-to-end wound care workflow platform. It delivers effective tracking, charting, and reporting of wound healing, including secure telehealth capabilities. The platform has been validated in over 180 pre-clinical to phase 4 clinical trials and is trusted by world-leading healthcare providers.

Therapeutic areas: Dermatology
Modalities: Device
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on ARANZ Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ARANZ Medical.

Explore the full profile